These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30210129)

  • 1. Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).
    Misumi K; Ogo T; Ueda J; Tsuji A; Fukui S; Konagai N; Asano R; Yasuda S
    Intern Med; 2019 Feb; 58(3):395-399. PubMed ID: 30210129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.
    Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
    Int Heart J; 2023; 64(2):316-320. PubMed ID: 37005323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal medicine Qing-Dai-induced pulmonary arterial hypertension in a patient with ulcerative colitis: A case report and experimental investigation.
    Sato K; Ohira H; Horinouchi T; Nakaya T; Mazaki Y; Sugimoto A; Watanabe T; Tsujino I; Nishimura M
    Respir Med Case Rep; 2019; 26():265-269. PubMed ID: 30815357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Frumkin Regarding Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.".
    Frumkin LR
    Int Heart J; 2023 Nov; 64(6):1166. PubMed ID: 37967984
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the Letter by Frumkin Regarding the Article, "Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis".
    Kubota K; Imai Y; Okuyama T; Ishiyama Y; Ueno S; Kario K
    Int Heart J; 2023; 64(6):1167. PubMed ID: 38030296
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of pulmonary arterial hypertension following long-term Qing-Dai use for ulcerative colitis.
    Inoue Y; Ishihara A; Mori T; Horio S; Yoshizane T; Arai M; Noda T
    J Cardiol Cases; 2023 May; 27(5):218-221. PubMed ID: 37180221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.
    Sugimoto S; Naganuma M; Kiyohara H; Arai M; Ono K; Mori K; Saigusa K; Nanki K; Takeshita K; Takeshita T; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hisamatsu T; Inoue N; Ogata H; Iwao Y; Kanai T
    Digestion; 2016; 93(3):193-201. PubMed ID: 26959688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.
    Suzuki H; Kaneko T; Mizokami Y; Narasaka T; Endo S; Matsui H; Yanaka A; Hirayama A; Hyodo I
    World J Gastroenterol; 2013 May; 19(17):2718-22. PubMed ID: 23674882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneously remitted pulmonary arterial hypertension associated with the herbal medicine "bofutsushosan".
    Sakurai Y; Tanabe N; Sekine A; Nishimura R; Jujo T; Kawasaki T; Sugiura T; Sakao S; Kasahara Y; Tatsumi K
    Intern Med; 2013; 52(13):1499-502. PubMed ID: 23812198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Oral Qing-Dai Medication on Pulmonary Arterial Pressure Levels in Patients With Ulcerative Colitis.
    Orihara Y; Asakura M; Hida N; Kawai M; Sato T; Nishimura K; Masai K; Matsumoto Y; Okuhara Y; Goda A; Masuyama T; Nakamura S; Ishihara M
    Circ J; 2020 Jul; 84(8):1339-1345. PubMed ID: 32595175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases.
    Kondo S; Araki T; Okita Y; Yamamoto A; Hamada Y; Katsurahara M; Horiki N; Nakamura M; Shimoyama T; Yamamoto T; Takei Y; Kusunoki M
    Clin J Gastroenterol; 2018 Aug; 11(4):268-272. PubMed ID: 29549501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Maintenance Effect of Qing Dai for Ulcerative Colitis.
    Suzuki H; Mizokami Y; Gosho M; Kaneko T; Matsui H; Yanaka A
    J Altern Complement Med; 2018 Nov; 24(11):1130-1131. PubMed ID: 29664682
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.
    Naganuma M; Sugimoto S; Suzuki H; Matsuno Y; Araki T; Shimizu H; Hayashi R; Fukuda T; Nakamoto N; Iijima H; Nakamura S; Kataoka M; Tamura Y; Tatsumi K; Hibi T; Suzuki Y; Kanai T;
    J Gastroenterol; 2019 Oct; 54(10):891-896. PubMed ID: 31102012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese herbal drug natural indigo may cause pulmonary artery hypertension.
    Nishio M; Hirooka K; Doi Y
    Eur Heart J; 2016 Jul; 37(25):1992. PubMed ID: 26984865
    [No Abstract]   [Full Text] [Related]  

  • 15. Qing-Dai for pediatric ulcerative colitis multicenter survey and systematic review.
    Kudo T; Jimbo K; Shimizu H; Iwama I; Ishige T; Mizuochi T; Arai K; Kumagai H; Uchida K; Abukawa D; Shimizu T
    Pediatr Int; 2022 Jan; 64(1):e15113. PubMed ID: 35831249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blue Polypoid Colorectal Lesions in a Woman With Ulcerative Colitis Taking Qing-Dai.
    Kato J; Yoshida T; Niwa T
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):A32. PubMed ID: 27094581
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of Pulmonary Arterial Hypertension During Qing-Dai Use for the Treatment of Ulcerative Colitis.
    Adachi S; Nakano Y; Kondo T
    Circ J; 2020 Jul; 84(8):1235-1236. PubMed ID: 32655110
    [No Abstract]   [Full Text] [Related]  

  • 18. Kui jie qing in the treatment of chronic non-specific ulcerative colitis.
    Wang B; Ren S; Feng W; Zhong Z; Qin C
    J Tradit Chin Med; 1997 Mar; 17(1):10-3. PubMed ID: 10437236
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
    Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
    Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole compounds may be promising medicines for ulcerative colitis.
    Sugimoto S; Naganuma M; Kanai T
    J Gastroenterol; 2016 Sep; 51(9):853-61. PubMed ID: 27160749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.